摘要
目的寻找更多具有治疗心脑血管疾病的潜在药物。方法通过磺酰化反应将不同取代的磺酰氯中间体连接到环维黄杨星D上,合成得到目标产物,并对其进行耐缺氧活性的研究。结果和结论共合成了7个环维黄杨星D磺酰化衍生物,其结构经IR、MS1、HNMR和高分辨质谱(HRMS)确证,且化合物2 a^2g均具有良好的药理活性,其中化合物2 e、2g作用最强,超过现有临床药物黄杨宁片。
OBJECTIVE To obtain more potential agents for the treatment of cardiovascular diseases. METHODS The target compounds were synthesized from the corresponding sulfonic acid chloride and Cyclovirobuxine D by sulfonamide acylation. RESULTS and CONCLUSION The structures of all compounds synthesized were determined by IR, MS, 1 HNMR and HRMS. Their effects on oxygen - deficient endurance in mice were primarily evaluated. The results indicated that all compounds possess efficiency on oxygen - defecient endurance, especially that compounds 2e, 2g were more active than clinical drug Cyclovirobuxinel tablet. These seven new compounds can promote the treatment capability of cardiovascular diseases.
出处
《华西药学杂志》
CAS
CSCD
北大核心
2006年第6期511-514,共4页
West China Journal of Pharmaceutical Sciences
关键词
环维黄杨星D
磺酰化
结构修饰
合成
耐缺氧活性
Cyclovirobuxine D
Sulfonamide
Structural modification
Synthesis
Oxygen - deficient endurance